
Lundbeck: Global Leader In Brain Health Innovation
Lundbeck stands as a pioneering global biopharmaceutical company exclusively dedicated to neuroscience, advancing brain health and transforming lives for over 70 years. Founded in 1915 and headquartered in Valby, Denmark, this publicly traded organization employs approximately 5,600 professionals across more than 50 countries, with significant U.S. operations in Deerfield, Illinois; La Jolla, California; and Bothell, Washington.
Specialized Neuroscience Expertise
As one of the world's few pharmaceutical companies focusing entirely on brain disorders-conditions affecting nearly half the global population-Lundbeck maintains a unique market position. The company covers the complete value chain from molecule to patient, developing breakthrough treatments for neuro-rare and neuro-specialty conditions. With research facilities in Denmark and the United States, plus production sites across Denmark, France, and Italy, Lundbeck has pioneered some of the most important therapies in antipsychotics and antidepressants.
Culture Built on Purpose
Lundbeck's culture emphasizes curiosity, accountability, and adaptability, fostering collaboration and responsibility across all teams. Whether working in laboratories, offices, or field positions, employees share a unified mission to develop transformative treatments for people living with brain disorders. The company actively fights stigma and discrimination while promoting better understanding and treatment parity across communities.
Career Growth and Comprehensive Benefits
- Competitive compensation with performance-based bonuses and long-term incentive plans
- Flexible paid time off (PTO) and comprehensive health coverage (Medical, Dental, Vision)
- 401(k) matching and company car benefits for eligible positions
- Field-based roles with extensive travel opportunities and professional autonomy
- Direct engagement with key opinion leaders and healthcare professionals
- Access to cutting-edge research and clinical trial initiatives
- Professional development in rapidly evolving neuroscience field
Impact Driven Work Environment
With annual revenues between $1-5 billion USD and backing from the Lundbeck Foundation-which donates approximately 500 million DKK annually to biomedical research-team members have the resources and stability to pursue meaningful work that directly impacts patient lives. Every role contributes to the company's mission of advancing brain health, making Lundbeck an ideal destination for healthcare professionals seeking purpose-driven careers.
Mission
Advancing brain health. Transforming lives.
Every day, we go to work to develop new and improved treatments that make a difference for people living with brain disorders. For decades, hard work and commitment have taken us far, but there is still a long way to go.
It's estimated that brain disorders directly affect half of the world's population. At Lundbeck, we take a holistic view of brain health, and believe it needs to be promoted and prioritized. Within brain disorders, we focus our efforts on neurology and psychiatry. Neurological disorders alone are a leading cause of disability, and the second-leading cause of death globally (accounting for 9 million deaths per year). In addition, the prevalence of mental health disorders is currently estimated at 970 million people causing 1 in 5 years lived with disability globally. Despite our knowledge about the brain, our strong heritage in the treatment of psychiatric and neurological disorders, and our engagement with those with lived experience, we recognize that significant challenges in brain health still remain.
Frequently Asked Questions

Eli Lilly and Company

Lilly

Jazz Pharmaceuticals

LifeStance Health

Pfizer

Planet Pharma

Abbott

Redbock - an NES Fircroft company

SonderMind

EVERSANA
